WATERTOWN, Mass. – V.T. Technologies, Inc. (VITEX), a biotechnology company dedicated to developing products that inactivate and remove pathogens in blood, has announced its financial results for the third quarter ended September 30, 2001.
For the third quarter of 2001, VITEX reported a net loss of $2.7 million, or $0.12 per share, compared to a net loss of $5.0 million or $0.25 per share, for the third quarter of 2000. Net revenues for the third quarter of 2001 were $5.2 million compared to $9.4 million for the third quarter of 2000.
PBN Branded Content
Seifert Systems Invests in Energy Efficiency to Strengthen Operations
For manufacturers, energy is more than just another operating expense. It plays a critical role…
Learn More
